ES286241A1 - Un procedimiento para la fabricación de derivados benzodiazepínicos - Google Patents

Un procedimiento para la fabricación de derivados benzodiazepínicos

Info

Publication number
ES286241A1
ES286241A1 ES286241A ES286241A ES286241A1 ES 286241 A1 ES286241 A1 ES 286241A1 ES 286241 A ES286241 A ES 286241A ES 286241 A ES286241 A ES 286241A ES 286241 A1 ES286241 A1 ES 286241A1
Authority
ES
Spain
Prior art keywords
translation
manufacture
machine
legally binding
*** translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES286241A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES286241A1 publication Critical patent/ES286241A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES286241A 1962-03-21 1963-03-20 Un procedimiento para la fabricación de derivados benzodiazepínicos Expired ES286241A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18144062A 1962-03-21 1962-03-21

Publications (1)

Publication Number Publication Date
ES286241A1 true ES286241A1 (es) 1963-11-16

Family

ID=22664289

Family Applications (1)

Application Number Title Priority Date Filing Date
ES286241A Expired ES286241A1 (es) 1962-03-21 1963-03-20 Un procedimiento para la fabricación de derivados benzodiazepínicos

Country Status (7)

Country Link
BR (1) BR6347165D0 (es)
CH (3) CH455814A (es)
DE (1) DE1445872A1 (es)
DK (1) DK107100C (es)
ES (1) ES286241A1 (es)
GB (1) GB1039372A (es)
SE (1) SE312808B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529203A1 (fr) * 1982-06-24 1983-12-30 Fabre Sa Pierre Procede industriel d'obtention et de purification de flunitrazepam de qualite pharmaceutique

Also Published As

Publication number Publication date
BR6347165D0 (pt) 1973-07-19
CH454888A (de) 1968-04-30
DK107100C (da) 1967-04-24
CH455814A (de) 1968-05-15
GB1039372A (en) 1966-08-17
CH441342A (de) 1967-08-15
DE1445872A1 (de) 1969-04-10
SE312808B (es) 1969-07-28

Similar Documents

Publication Publication Date Title
ES286241A1 (es) Un procedimiento para la fabricación de derivados benzodiazepínicos
ES319653A1 (es) Un procedimiento para la preparacion de derivados de imidazol.
ES465346A1 (es) Procedimiento para preparar imidazoles 4,5-disustituidos.
ES285855A1 (es) Un procedimiento para la fabricación de derivados benzodiazepínicos
ES276648A1 (es) Procedimiento para la fabricación de derivados de benzodiazepina
ES285790A1 (es) Procedimiento para la producción de succinimidas
ES292054A1 (es) Procedimiento de preparación de un derivado de la benzotiadiacina, de acción hipotensiva
ES310607A1 (es) Procedimiento para preparar imidazoles, isoindoles y dihidroisoquinolinas.
ES264004A1 (es) Procedimiento para la fabricaciën de compuestos benzodiazepinicos que contienen fluor
ES298897A1 (es) Un procedimiento para la preparación de derivados de benzodiazepina
ES308607A1 (es) Un procedimiento para la preparacion de un compuesto de 2- alcohiltiofeno.
ES383586A1 (es) Un procedimiento para producir derivados de 1-hidroxialco- hil - benzodiazepina.
ES247168A1 (es) Un procedimiento para producir nuevos compuestos heterociclicos saturados fenil sustituidos
ES430140A1 (es) Procedimiento para la obtencion de (2-oxo-pirrolidin-1-)- acetamida.
ES382147A1 (es) Un procedimiento para preparar compuestos de morfolina n- sustituidos.
ES283029A1 (es) Procedimiento para la fabricación de derivados benzodiazepínicos
ES299359A1 (es) Procedimiento para producir compuestos de guanidina sustituidos
ES287549A1 (es) Procedimiento para la producción del ácido n-(2,3-dimetilfenil)-antranílico y sus sales
ES272321A1 (es) Procedimiento para la preparación de compuestos de adición de hidrazina
ES248822A1 (es) Un método para preparar nuevos compuestos de tetraciclina
ES374449A1 (es) Procedimiento para la preparacion de derivados de serina.
ES320857A1 (es) Un procedimiento para la produccion de derivados de fenantreno.
ES379624A1 (es) Procedimiento para producir compuestos de pirazol-diazepi- nona.
ES310642A2 (es) Procedimiento para la fabricacion de nuevas fenil-ciclohexilalquilaminas y sus sales
ES413737A1 (es) Un procedimiento para la preparacion de compuestos de acidol-alfa-hidrazino-beta-fenilpropionico.